Video

ASCRS Live: Analysis in two subgroups of routine cataract surgery

Edward Hu, MD, PhD, discussed his paper on the single surgeon retrospective comparative analysis of 517 eyes of two subgroups of routine cataract surgery at the 2023 ASCRS annual meeting in San Diego.

Edward Hu, MD, PhD, discussed his paper on the single surgeon retrospective comparative analysis of 517 eyes of two subgroups of routine cataract surgery at the 2023 ASCRS annual meeting in San Diego.

Video transcript

Editor’s note: Transcript lightly edited for clarity.

Edward Hu, MD, PhD:

Hello, I'm Dr. Edward Hu, cataract specialist with the Wolfe Eye Clinic in Iowa, and I wanted to share with you some results of a paper I presented at the 2023 ASCRS meeting in San Diego. I presented a paper regarding a single surgeon retrospective comparative analysis of 517 eyes in which they were broken down into two subgroups of routine cataract surgery. One group had had prior refractive surgery, either LASIK or PRK versus the second subgroup which had not had prior refractive surgery.

We analyze the outcomes in terms of vision. and understandably, preoperatively, the refractive group had slightly better visual acuities because they had undergone refractive surgery. Postoperatively, interestingly, the refractive group had slightly better visual outcomes than the patients that had not undergone refractive surgery. Our conclusion is that the monofocal IOL, with the aberration-free design of the Bausch + Lomb enVista likely had contributed to these great outcomes in both subgroups.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
At the 2025 American Society of Cataract and Refractive Surgery (ASCRS) meeting, Seth Pantanelli, MD, speaks about the EyHance and enVista IOLs. Dr. Pantanelli is a professor of ophthalmology at Penn State College of Medicine in Hershey, Pennsylvania.
(Image credit: Ophthalmology Times) ASCRS 2025: Eric D. Donnenfeld, MD, on the effect of lifitegrast clinical signs and biomarkers in dry eye disease
© 2025 MJH Life Sciences

All rights reserved.